02/03/07
Recommendation for revision of the Guideline on the clinical development of medicinal products for the treatment of hiv infection (CPMP/EWP/633/02 rev. 1)
02/03/07
Recommendation on the need for revision of (CHMP) Points to onsider on the requirements for clinical documentation for orally inhaled products (OIP) (CPMP/EWP/4151/00)
02/03/07
Points to Consider on Clinical Investigation of Medicinal Products for the Management of Crohn's Disease
02/03/07
Recommendation for revision of the points to consider on the evaluation of diagnostic agents
0 件のコメント:
コメントを投稿